Kedrion Biopharma US Email Format

Pharmaceutical ManufacturingNew Jersey, United States201-500 Employees

Kedrion Biopharma US operates within the pharmaceutical manufacturing sector, focusing on plasma-derived therapies. The company collects and fractionates plasma to produce and distribute a portfolio of medicines that address rare and ultra-rare diseases, reflecting a mission to enhance patients’ lives through specialized products. Based in Fort Lee, New Jersey, Kedrion Biopharma US is part of a global organization that emphasizes a long-standing commitment to donors, patients, and healthcare partners, describing its approach as prioritizing careful, meaningful connections throughout the care continuum.

In the broader market, the firm positions itself in the plasma-derived products industry, collaborating with medical and scientific communities, patient advocacy groups, and research organizations to advance sustainable innovation. Recent developments include the launch of QIVIGY in the United States and participation in industry events during 2026, signaling ongoing efforts to expand access to high-quality plasma-derived therapies and to engage with broader healthcare ecosystems.

Get verified Kedrion Biopharma US emails free

Company overview Employee directory